Structural insights into the assembly and polyA signal recognition mechanism of the human CPSF complex by Clerici, Marcello et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Structural insights into the assembly and polyA signal recognition
mechanism of the human CPSF complex
Clerici, Marcello; Faini, Marco; Aebersold, Ruedi; Jinek, Martin
Abstract: 3’ polyadenylation is a key step in eukaryotic mRNA biogenesis. In mammalian cells, this pro-
cess is dependent on the recognition of the hexanucleotide AAUAAA motif in the pre-mRNA polyadenyla-
tion signal by the cleavage and polyadenylation specificity factor (CPSF) complex. A core CPSF complex
comprising CPSF160, WDR33, CPSF30 and Fip1 is sufficient for AAUAAA motif recognition, yet the
molecular interactions underpinning its assembly and mechanism of PAS recognition are not understood.
Based on cross-linking-coupled mass spectrometry, crystal structure of the CPSF160-WDR33 subcom-
plex and biochemical assays, we define the molecular architecture of the core human CPSF complex,
identifying specific domains involved in inter-subunit interactions. In addition to zinc finger domains in
CPSF30, we identify using quantitative RNA-binding assays an N-terminal lysine/arginine-rich motif in
WDR33 as a critical determinant of specific AAUAAA motif recognition. Together, these results shed
light on the function of CPSF in mediating PAS-dependent RNA cleavage and polyadenylation.
DOI: https://doi.org/10.7554/eLife.33111
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-144962
Published Version
 
 
Originally published at:
Clerici, Marcello; Faini, Marco; Aebersold, Ruedi; Jinek, Martin (2017). Structural insights into the
assembly and polyA signal recognition mechanism of the human CPSF complex. eLife, 6:e33111.
DOI: https://doi.org/10.7554/eLife.33111
*For correspondence: jinek@bioc.
uzh.ch
Competing interests: The
authors declare that no
competing interests exist.
Funding: See page 16
Received: 26 October 2017
Accepted: 21 December 2017
Published: 23 December 2017
Reviewing editor: Nick J
Proudfoot, University of Oxford,
United Kingdom
Copyright Clerici et al. This
article is distributed under the
terms of the Creative Commons
Attribution License, which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
Structural insights into the assembly and
polyA signal recognition mechanism of
the human CPSF complex
Marcello Clerici1, Marco Faini2, Ruedi Aebersold2,3, Martin Jinek1*
1Department of Biochemistry, University of Zurich, Zurich, Switzerland; 2Department
of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland;
3Faculty of Science, University of Zurich, Zurich, Switzerland
Abstract 3’ polyadenylation is a key step in eukaryotic mRNA biogenesis. In mammalian cells,
this process is dependent on the recognition of the hexanucleotide AAUAAA motif in the pre-
mRNA polyadenylation signal by the cleavage and polyadenylation specificity factor (CPSF)
complex. A core CPSF complex comprising CPSF160, WDR33, CPSF30 and Fip1 is sufficient for
AAUAAA motif recognition, yet the molecular interactions underpinning its assembly and
mechanism of PAS recognition are not understood. Based on cross-linking-coupled mass
spectrometry, crystal structure of the CPSF160-WDR33 subcomplex and biochemical assays, we
define the molecular architecture of the core human CPSF complex, identifying specific domains
involved in inter-subunit interactions. In addition to zinc finger domains in CPSF30, we identify
using quantitative RNA-binding assays an N-terminal lysine/arginine-rich motif in WDR33 as a
critical determinant of specific AAUAAA motif recognition. Together, these results shed light on
the function of CPSF in mediating PAS-dependent RNA cleavage and polyadenylation.
DOI: https://doi.org/10.7554/eLife.33111.001
Introduction
The 3’-terminal polyA tail of eukaryotic mRNAs is generated by a two-step process consisting of an
initial endonucleolytic cleavage of the nascent RNA transcript followed by polyadenylation of the
upstream cleavage fragment by polyA polymerase (PAP) (Chan et al., 2011; Shi and Manley, 2015).
Although 3’-polyadenylation is an obligatory step in the biogenesis of non-histone mRNAs, many
eukaryotic genes contain alternative polyadenylation sites that generate different protein isoforms,
or mRNA isoforms with variable 3’-untranslated regions (UTRs), thereby modulating their ability to
interact with microRNAs and 3’-UTR interacting factors (Derti et al., 2012; Elkon et al., 2013;
Hoque et al., 2013; Tian and Manley, 2017). The selection of a specific polyadenylation site is a
dynamically regulated process during cell differentiation, proliferation and development
(Sandberg et al., 2008; Ji et al., 2009; Shepard et al., 2011; Graber et al., 2013), making mRNA
polyadenylation a key mechanism of gene expression control.
In mammalian cells, the principal cis-acting motif within the polyadenylation signal (PAS) that
defines the site of cleavage and polyadenylation is a hexanucleotide A(A/U)UAAA sequence
(Proudfoot and Brownlee, 1976; Chan et al., 2011). This sequence motif (also referred to as the
PAS hexamer motif or AAUAAA motif) is typically located approximately 10–30 nucleotides
upstream of the endonucleolytic cleavage site, which is generally marked by the sequence CA
(Sheets et al., 1990). The key protein factor responsible for polyA site definition is the cleavage and
polyadenylation specificity factor (CPSF), a multisubunit complex that specifically recognizes the
AAUAAA motif, catalyzes pre-mRNA cleavage, and recruits PAP to initiate polyadenylation at the 3’
hydroxyl group of the upstream cleavage fragment. (Takagaki et al., 1988; Keller et al., 1991).
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Other cis-elements in the vicinity of the AAUAAA motif that contribute to the definition of the polyA
site include upstream UGUA-containing sequences (USE) (Carswell and Alwine, 1989;
Brackenridge and Proudfoot, 2000) and downstream G- and GU-rich sequences (DSE) (Gil and
Proudfoot, 1984; McLauchlan et al., 1985; Gil and Proudfoot, 1987). These elements are recog-
nized by the cleavage factor I (CFI) and the cleavage stimulation factor (CstF) complexes, respec-
tively (Shi and Manley, 2015), both of which contribute to polyA site definition and its regulation.
The initial biochemical characterization of CPSF revealed the presence of four subunits: CPSF160,
CPSF100, CPSF73 and CPSF30 (Bienroth et al., 1991; Murthy and Manley, 1992). Two additional
subunits integral to CPSF, Fip1 and WDR33, which are homologous to the yeast 3’ processing fac-
tors Fip1p and Pfs2p, respectively, were identified at a later stage (Kaufmann et al., 2004;
Shi et al., 2009). RNA cleavage is catalyzed by CPSF73, a zinc-dependent endonuclease that con-
tains a metallo-beta-lactamase domain and a beta-CASP domain. CPSF73 has very weak enzymatic
activity in isolation, implying that other CPSF subunits or 3’-end processing factors are required for
efficient cleavage (Ryan et al., 2004; Mandel et al., 2006). CPSF100, despite its high structural simi-
larity to CPSF73, is catalytically inactive and its function is hitherto unknown (Mandel et al., 2006). In
turn, CPSF160, WDR33, CPSF30 and Fip1 have been shown to form a stable complex independently
of CPSF100 and CPSF73 (Scho¨nemann et al., 2014). This ‘core’ polyadenylation module of the
CPSF complex is able to bind to an RNA containing the AAUAAA motif with nanomolar affinity
(KD ~2 nM) and to promote its polyadenylation by PAP (Scho¨nemann et al., 2014). Although
CPSF160 had originally been identified as the subunit that mediates PAS hexamer motif recognition
(Murthy and Manley, 1995; Dichtl et al., 2002), recent studies employing UV cross-linking have
indicated that CPSF30 and WDR33 directly interact with the PAS hexamer instead (Chan et al.,
2014; Scho¨nemann et al., 2014). CPSF30 contains five consecutive zinc finger (ZF) domains and a
C-terminal zinc knuckle domain (Barabino et al., 1997). The RNA binding activity of CPSF30 is pri-
marily mediated by the second and third ZF domains (Chan et al., 2014). This region of CPSF30 is
also targeted by the NS1 protein of the influenza virus, enabling the virus to inhibit the polyadenyla-
tion of host mRNAs encoding innate immunity factors (Das et al., 2008). Fip1 has been shown to
regulate alternative polyadenylation (APA) in embryonic stem cells (Lackford et al., 2014). Consis-
tent with these findings, interactions between Fip1 and uridine-rich RNA motifs located upstream of
the PAS hexamer motif have been mapped in vivo and in vitro, suggesting that Fip1 plays an impor-
tant role in modulating PAS selection (Martin et al., 2012; Chan et al., 2014; Lackford et al.,
2014).
Despite its importance for mRNA biogenesis and the regulation of gene expression, the molecu-
lar architecture of the CPSF complex and its mechanism of PAS hexamer motif recognition are
poorly understood. Here, we present structural and functional insights into the assembly of the core
AAUAAA-binding module of the human CPSF complex. We show that CPSF160 and WDR33 form
an heterodimer independently of the other CPSF subunits and report a 2.5 A˚-resolution crystal struc-
ture of the subcomplex. We further reveal that CPSF30 orchestrates the assembly of the quaternary
core CPSF module complex by bridging CPSF160-WDR33 with Fip1. Finally, we show that in addi-
tion to CPSF30 ZF domains, specific recognition of the PAS hexamer is mediated by the N-terminal
region of WDR33. These results establish a framework for further mechanistic studies of the CPSF
complex in eukaryotic mRNA polyadenylation.
Results
A core module containing the N-terminal WD40 domain of WDR33 is
sufficient for PAS recognition by CPSF
A recent study demonstrated that a four-subunit CPSF core complex containing WDR33 is necessary
and sufficient to support AAUAAA motif-dependent polyadenylation in vitro (Scho¨nemann et al.,
2014). Human WDR33 is a ~145 kDa protein composed of an N-terminal WD40 beta-propeller
domain and a poorly conserved C-terminal region containing low-complexity sequences. To shed
light on the assembly of the CPSF polyadenylation module, we first reconstituted by co-expression
in Sf9 insect cells a minimal complex consisting of full-length human CPSF160 (CPSF160FL), CPSF30
(CPSF30FL) and Fip1 (Fip1FL) proteins, and a fragment of WDR33 comprising only the N-terminal
region containing the WD40 domain (WDR33M1-K410) (Figure 1—figure supplement 1A). We then
Clerici et al. eLife 2017;6:e33111. DOI: https://doi.org/10.7554/eLife.33111 2 of 20
Research article Biochemistry Biophysics and Structural Biology
tested whether the reconstituted complex is capable of specific binding to an RNA containing the
PAS hexamer motif. To this end, we used a Atto532-labelled 16-nucleotide RNA containing the
AAUAAA hexamer and tested its binding in a fluorescence polarization assay (Figure 1A). The RNA
was bound with sub-nanomolar affinity (KD = 0.65 ± 0.09 nM), in general agreement with a previously
reported value (KD ~2 nM) (Scho¨nemann et al., 2014). By contrast, the affinity of the complex for a
mutated version of the RNA containing a single nucleotide substitution in the hexanucleotide
(AAGAAA) was reduced by more than 100-fold (Figure 1A). Together, these results indicate that a
core module of the CPSF complex containing the WD40 domain of WDR33 is able to bind the
AAUAAA motif with both high affinity and specificity, implying that the C-terminal region of WDR33
is not necessary for CPSF assembly and PAS recognition.
To dissect inter- and intra-subunit interactions within the CPSF core module, we used cross-link-
ing coupled to mass spectrometry on a variant of the minimal CPSF complex described above, carry-
ing a C-terminally extended version of WDR33 (WDR33M1-G474, Figure 1—figure supplement 1A,
B). To this end, we used the cross-linking agent disuccinimidyl suberate (DSS), which cross-links
lysine residues located within approximately 35 A˚ of each other, and identified cross-linked peptides
by mass spectrometry. We identified 54 and 99 validated inter- (Figure 1B) and intra-protein (Fig-
ure 1—figure supplement 1C) cross-linked sites, respectively (as judged by xQuest score higher
than 30, corresponding to an approximate false discovery rate of 10%, Figure 1—source data 1).
The cross-links cover most of the sequences and structured domains of the constituent subunits. We
observe distinct cross-linking patterns of CPSF160 to the other three subunits. Whereas Fip1 forms
cross-links along the entire CPSF160 sequence, WDR33 and CPSF30 cross-links mostly to the middle
and C-terminal regions of CSPF160, respectively. Notably, lysine residues K46, K50 and K55 in the
N-terminal region of WDR33 upstream of the predicted WD40 domain form a cross-linking hotspot,
interacting extensively with the central part of CSPF160, all five zinc finger domains of CPSF30 and a
central, highly conserved region of Fip1 (Figure 1B). Additionally, we identify numerous cross-links
between the conserved Fip1 region and the zinc finger and the C-terminal zinc knuckle domains of
CPSF30. Finally, cross-links from CSPF160 residues map exclusively to CPSF30 zinc finger domains
ZF1 and ZF2 (spanning residues K35-K92). Together, these results highlight extensive inter-subunit
interactions within the polyA signal-binding core module of the CPSF complex and further under-
score the critical role played by WDR33 in the assembly of the CPSF complex.
Crystal structure of the CPSF160-WDR33 heterodimer reveals the
structural scaffold of the CPSF complex
To gain insights into the molecular architecture of the CPSF core complex, we reconstituted and
crystallized a heterodimeric complex consisting of CPSF160FL (residues M1-F1443) and an N-terminal
WDR33 fragment encompassing residues Q35-K410 (WDR33Q35-K410, Figure 1—figure supplement
1A). The structure of the complex was solved at 2.5 A˚ resolution by a combination of molecular
replacement and tantalum bromide (Ta6Br12) and sulphur single-wavelength anomalous dispersion
(SAD), refined to an Rfree factor of 26.2% (Table 1). The structure revealed that CPSF160 is a multi-
domain protein composed of three seven-bladed WD40 beta-propeller domains (bP1, bP2 and bP3
for beta propeller 1 to 3) and a C-terminal helical domain (CTD). The three beta-propellers form a
compact tristar arrangement (Figure 2A), reminiscent of the domain arrangement observed in the
DNA Damage Binding protein 1 (DDB1) (Li et al., 2006) (Figure 2—figure supplement 1A). The
central beta-propeller domain (bP2) is located at the top of the bP1-bP3 contact region, with the
CTD sealing the interaction between the three beta-propellers at their central junction (Figure 2A,
side view). The N- and C-terminal propellers (bP1 and bP3) are oriented in a pseudosymmetric fash-
ion and interact with each other at a ~60˚ angle, creating a deep cavity in between. The cavity is
closed on the distal side by three elongated loops (el1-el3) comprising residues P223-T237 (el1),
L300-C324 (el2) and C1044-K1069 (el3) projecting from bP1 and bP3 (Figure 2—figure supplement
2A). CPSF160 and DDB1 share a remarkable structural similarity despite low sequence identity
(~16%), in particular for the bP1-bP3-CTD ensemble (RMSD 2.5 A˚ for 737 aligned Ca atoms) (Fig-
ure 2—figure supplement 1A). However, in contrast to DDB1, bP2 is tightly packed against the
other two propeller domains and CTD in CPSF160, making extensive ionic and hydrophobic interac-
tions (~3600 A˚2 of total buried area and 54 charged interactions for CPSF160 in comparison
to ~1000 A˚2 and 10 interactions for DDB1). This tight packing suggests that bP2 is locked in a fixed
position in CPSF160, whereas different crystal forms show significant conformational flexibility of
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Figure 1. Characterization of the CPSF160-WDR33M1-K410-CPSF30-Fip1 complex. (A) Equilibrium binding of
CPSF160FL-WDR33M1-K410-CPSF30FL -Fip1FL to an Atto532-labelled, 16-nucleotide RNA containing the PAS
hexanucleotide (AAUAAA), measured by fluorescence polarization. The polarization amplitude is normalized to 1.
Error bars indicate standard error of means (SEM) for five consecutive measurements of a single representative
Figure 1 continued on next page
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bP2 in DDB1 (Li et al., 2006) (Figure 2—figure supplement 1A). As in DDB1, the three beta-pro-
peller domains of CPSF160 do not follow a linear tandem topology; instead, three discontinuous
regions of the CPSF160 polypeptide sequence contribute to bP3 (Figure 1B).
WDR33 also forms a seven-bladed beta-propeller domain (corresponding to residues T108-T403)
and additionally contains a ~50 residue N-terminal domain (NTD, residues R54-T107) protruding
away from the beta-propeller (Figure 1A and Figure 2B). The NTD has a unique fold with no sec-
ondary structure features except for an N-terminal alpha-helix. The NTD is further supported by a
short loop (residues R404-K410) extending C-terminally from the last beta-strand of the WD40 pro-
peller. Upstream of the NTD, residues Q35-N53, which were included in the crystallized protein con-
struct, are disordered in the crystal structure and could not be modeled (Figure 2B). The WDR33
NTD is completely buried in the cavity formed by CPSF160 bP1 and bP3 (Figure 2C and Figure 2—
figure supplement 2B), with CPSF160 loops el1, el2 and el3 locking the NTD in place (Figure 2—
figure supplement 2A). The CPSF160-WDR33 complex is further stabilized by contacts between
WDR33 beta-propeller domain and CPSF160 bP1 and bP3. The CPSF160-WDR33 interaction is strik-
ingly reminiscent of the architecture of the DDB1-DDB2 DNA repair complex (Scrima et al., 2008).
Superposition of CPSF160 and DDB1 results in almost perfect overlap of the N-terminal alpha-heli-
ces of WDR33 and DDB2. However, due to local differences in the N-terminal domains WDR33 and
DDB2, the respective beta-propeller domains of the two proteins are shifted by ~10 A˚ relative to
each other (Figure 2—figure supplement 1B,C). Overall, CPSF160 and WDR33 establish an exten-
sive network of interactions encompassing 45 hydrogen bonds and 19 salt bridges, with a total bur-
ied surface of ~6900 A˚2, equally distributed over the two proteins. These structural observations are
thus consistent with CPSF160 and WDR33 forming a tight heterodimeric subcomplex within the
polyA signal-binding module of the human CPSF complex.
The molecular architecture of the CPSF160-WDR33 heterodimer is in good agreement with our
cross-linking mass spectrometry data (Figure 1B and Figure 1—source data 1), despite many of the
cross-links originating from lysine residues within disordered regions of CPSF160 (internal loops) and
WDR33 (N-terminal region). Among the cross-links that can be mapped on the atomic model of the
CPSF160-WDR33 heterodimer, 12 are consistent with the conventional Euclidean distance of 35 A˚.
Notably, of the six cross-links with distance violations, five originate from the same CPSF160 residue
(see Materials and methods). Four cross-links between CPSF160 K1055 located in loop el3 and
WDR33 residues K46, K50, K55 and K410 are consistent with the CPSF160 beta-propeller three
being in proximity of the N-terminal region of WDR33 (Figure 1B and Figure 2A).
Molecular topology of the core CPSF complex
In light of the crystal structure of the CPSF160-WDR33 heterodimer, we sought to investigate the
physical interactions linking CPSF30 and Fip1 to CPSF160-WDR33 within the AAUAAA-binding core
module of CPSF. To this end, we co-expressed CPSF160FL and WDR33M1-K410 together with a series
of N-terminally green fluorescent protein (GFP)-tagged constructs of CPSF30 in Sf9 cells, making
Figure 1 continued
sample. Each binding experiment was performed in triplicate and the mean KDvalues ± SEM are reported in
Table 2. (B) Inter-subunit cross-link map of the CPSF160FL-WDR33M1-G474-CPSF30FL-Fip1FL complex. Observed
inter-molecular cross-links between CPSF160FL, WDR33M1-G474 and CPSF30FL (upper panel) and between FipFL and
the other three CPSF subunits CPSF160FL, WDR33M1-G474 and CPSF30FL (lower panel) are represented as dashed
lines. A list of the cross-linked peptides identified by mass spectrometry is reported in Figure 1—source data 1.
Proteins are indicated as schematic diagrams (not to scale) with featured domains highlighted in color. (CD, Fip1
conserved domain; ZF1-5, CPSF30 zinc finger domains 1 to 5; ZK, CPSF30 zinc knuckle domain; CTD, CPSF160
C-terminal domain; bP1-3, CPSF160 beta-propeller domains 1 to 3; NTD, WDR33 N-terminal domain. CPSF160:
Uniprot Q10570; WDR33: Uniprot Q9C0J8-1; CPSF30: Uniprot O95639-3; Fip1: Uniprot Q6UN15-4).
DOI: https://doi.org/10.7554/eLife.33111.002
The following source data and figure supplement are available for figure 1:
Source data 1. Table of cross-linking MS identification.
DOI: https://doi.org/10.7554/eLife.33111.004
Figure supplement 1. Reconstitution of the CPSF core module and intra-subunit cross-links.
DOI: https://doi.org/10.7554/eLife.33111.003
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use of the GFP tag for direct in-gel detection (Figure 3A, Figure 1—figure supplement 1A). In tan-
dem affinity purifications utilizing the His6-(StrepII)2 epitope tag on WDR33, we initially observed effi-
cient co-precipitation of full-length CPSF30 (CPSF30FL, Figure 3A, lane 1), indicating that CPSF30 is
able to interact with CPSF160FL-WDR33M1-K410 independently of Fip1. Next, we examined a series
of CPSF30 construct with different C-terminal deletions (Figure 3A, lanes 2–4). All tested CPSF30
constructs retained binding to CPSF160FL-WDR33M1-K410, indicating that the N-terminal ~60 residues
of CPSF30 that include ZF1 are sufficient for the interaction with CPSF160-WDR33 (Figure 3A, lane
4). Moreover, deletion of the same residues indeed impaired CPSF30 binding to CPSF160FL-
WDR33M1-K410 (CPSF30ZF2-5, Figure 3A, lane 5). A similar result was obtained when the N-terminal
34 residues of CPSF30 (upstream of ZF1) were deleted (CPSF30ZF1-5DN, Figure 3A, lane 6), but these
residues alone were not sufficient to mediate binding to CPSF160FL-WDR33M1-K410 (CPSF30N,
Table 1. Data collection and refinement statistics.
CPSF160-WDR33
Dataset Native Sulfur SAD Ta6Br12 SAD
X-ray source SLS X06DA (PXIII) SLS X06DA (PXIII) SLS X06DA (PXIII)
Space group P1 P1 P1
Cell dimensions
a, b, c (A˚) 67.91 77.40 104.02 67.88 77.58 104.14 67.52 76.79 104.02
a, b, g (o) 87.56 76.41 67.00 87.39 76.60 66.76 87.36 76.72 66.30
Wavelength (A˚) 1.0000 2.0733 1.2548
Resolution (A˚)* 47.27–2.50 (2.59–2.50) 44.25–3.00 (3.11–3.00) 47.26–3.60 (3.73–3.60)
Rmerge* 0.090 (0.773) 0.211 (2.934) 0.140 (0.669)
CC1/2* 0.999 (0.834) 0.999 (0.847) 0.998 (0.926)
I/sI* 18.3 (2.5) 29.3 (2.5) 20.6 (4.6)
Observations* 488656 (34882) 2456831 (165849) 300048 (29753)
Unique reflections* 65410 (6519) 37770 (3688) 21497 (2126)
Multiplicity* 7.5 (5.4) 65.0 (45.0) 14.0 (14.0)
Completeness (%)* 100.0 (100.0) 100.0 (96.9) 99.9 (99.6)
Refinement
Resolution (A˚) 47.27–2.50
No. reflections 65395 (6517)
Rwork/Rfree 0.228/0.263
No. atoms
Protein 12162
Water 102
B-factors
mean 69.35
Protein 69.52
Water 49.03
R.m.s. deviations
Bond lengths (A˚) 0.002
Bond angles (o) 0.56
Ramachandran plot
% favored 94.6
% allowed 5.4
% outliers 0.0
DOI: https://doi.org/10.7554/eLife.33111.008
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Figure 2. Crystal structure of the CPSF160-WDR33 complex. (A) Cartoon representation of the overall structure of the CPSF160FL-WDR33Q35-K410
complex. (B) Cartoon representation of the isolated WDR33 WD40 (light orange) and NTD (dark orange) domains. The N and C-termini are indicated as
dashed lines. (C) CPSF160 beta-propeller domains bP1 and bP3 form a deep cavity that binds the WDR33 N-terminal domain (NTD). A vertical cross-
section through the CPSF160 propeller domains (represented as surface) is shown. WDR33 is represented as cartoon.
Figure 2 continued on next page
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Figure 3A, lane 7). Together, these results indicate that the N-terminal region of CPSF30 up to and
including ZF1 is necessary and sufficient to mediate the interaction between CPSF30 and the
CPSF160-WDR33 heterodimer.
To probe the interactions of Fip1 with the other subunits, we co-expressed in Sf9 cells GFP-
tagged Fip1FL (Figure 1—figure supplement 1A) with CPSF160FL and His6-(StrepII)2-tagged
WDR33M1-K410 in the presence or absence of CPSF30FL and performed a pull-down experiment. In
the presence of CPSF30FL, Fip1FL was efficiently co-precipitated together with the rest of the
Figure 2 continued
DOI: https://doi.org/10.7554/eLife.33111.005
The following figure supplements are available for figure 2:
Figure supplement 1. The CPSF160-WDR33 heterodimer resembles the DDB1-DDB2 complex.
DOI: https://doi.org/10.7554/eLife.33111.006
Figure supplement 2. WDR33 is buried within the cavity formed by CPSF160 bP1 and bP3 domains.
DOI: https://doi.org/10.7554/eLife.33111.007
C
P
S
F
3
0
F
L
C
P
S
F
3
0
Z
F
1
-5
C
P
S
F
3
0
Z
F
1
-3
C
P
S
F
3
0
Z
F
1
C
P
S
F
3
0
Z
F
2
-5
C
P
S
F
3
0
Z
F
1
-5
 ∆
N
C
P
S
F
3
0
N
CPSF160
WDR33
GFP-CPSF30
*
250
130
100
70
55
35
25
kDa
0.03% input
1 432 65 7
G
F
P
 
C
P
S
F
3
0
F
L
C
P
S
F
3
0
Z
F
1
-5
C
P
S
F
3
0
Z
F
1
-4
C
P
S
F
3
0
Z
F
1
-3
C
P
S
F
3
0
Z
F
1
C
P
S
F
3
0
Z
F
4
-5
CPSF160
WDR33
CPSF30
250
130
100
70
55
35
25
kDa
GFP-Fip1CD
15
10
G
F
P
 
1 432 65
CPSF160 - WDR33
A B C
0.003% input
CPSF160FL
WDR33M1-K410
CPSF30FL
*
250
130
100
70
55
35
25
kDa
G
F
P
Input
CPSF30FL + - + -
Fip1FL Fip1CD
GFP-Fip1FL
GFP-Fip1CD`
1 432
Figure 3. Molecular topology of the CPSF complex. (A) CPSF30 ZF1 is necessary and sufficient for CPSF160FL-WDR33M1-K410 binding. Pull-down assay
of GFP-labeled CPSF30 constructs interacting with CPSF160FL-WDR33M1-K410. Input and bound proteins were analyzed on a 4–12% gradient SDS-PAGE
and visualized by Coomassie staining (upper panel) and by in-gel GFP fluorescence (middle and lower panels). The asterisk indicates free GFP present
in the input lysate. (B) Fip1 is tethered to the CPSF complex by its short conserved domain (Fip1CD). Pull-down assay of GFP-labeled Fip1FL and Fip1CD
interacting with the CPSF160FL-WDR33M1-K410-CPSF30FL complex. Input and bound proteins were analyzed on a 4–12% gradient SDS-PAGE and
visualized by Coomassie staining (upper panel) and by in-gel GFP fluorescence (middle and lower panels). The asterisk indicates free GFP present in
the input lysate. (C) CPSF30 zinc finger domains ZF4 and ZF5 are necessary and sufficient to mediate the interaction with Fip1. Pull-down assay of GFP-
labeled Fip1CD interacting with CPSF160FL-WDR33M1-K410-CPSF30. Input and bound proteins were analyzed on a 4–12% gradient SDS-PAGE and
visualized by Coomassie staining (upper panel) and by in-gel GFP fluorescence (middle and lower panels). In lane 6, His6-(StrepII)2-CPSF30
ZF4-5 was
used for the precipitation of GFP-Fip1CD, in the absence of WDR33M1-K410 and CPSF160FL.
DOI: https://doi.org/10.7554/eLife.33111.009
The following figure supplements are available for figure 3:
Figure supplement 1. The conserved middle domain of Fip1 (Fip1CD) interacts with CPSF30 zinc finger domains ZF4 and ZF5.
DOI: https://doi.org/10.7554/eLife.33111.010
Figure supplement 2. Mapping of CPSF30 and Fip1 cross-links onto the structure of CPSF160-WDR33.
DOI: https://doi.org/10.7554/eLife.33111.011
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complex (Figure 3B, lane 1). In contrast, Fip1FL did not interact with CPSF160FL and WDR33 M1-K410
in the absence of CPSF30FL expression (lane 2). Human Fip1 contains a central sequence motif that
is highly conserved across organisms, including yeast (Figure 3—figure supplement 1A). A ~7 kDa
fragment encompassing this conserved motif, spanning residues G130-K195, (henceforth termed the
Fip1 conserved domain, Fip1CD, Figure 1—figure supplement 1A), retained the ability to interact
with the CPSF30FL-CPSF160FL-WDR33 M1-K410 complex (Figure 3B, lane 3). As for Fip1FL, binding
was dependent on the presence of CPSF30FL (Figure 3B, lanes 3–4), indicating that a direct physical
interaction between CPSF30 and Fip1CD is required to recruit Fip1 to the CPSF core module. Alto-
gether, these results thus indicate that Fip1 is tethered to the CPSF complex via CPSF30, although
additional weaker interactions with CPSF160 and WDR33 cannot be excluded based on our cross-
linking and mass spectrometry data (Figure 1B). Moreover, the conservation of the Fip1CD motif
suggests that this mode of interaction is also conserved in the yeast CPF complex, the functional
equivalent of metazoan CPSF.
To delineate specific domains in CPSF30 responsible for Fip1 interaction, we conducted further
co-precipitation experiments using GFP-tagged Fip1CD and C-terminally truncated CPSF30 variants.
Whereas both CPSF30FL and a construct comprising all five ZF domains (CPSF30ZF1-5) exhibited
binding to Fip1 (Figure 3C, lanes 1–2), constructs lacking just ZF5 (CPSF30ZF1-4, Figure 3C, lane 3)
or additional ZF domains (CPSF30ZF1-3 and CPSF30ZF1, Figure 3C, lanes 4–5) showed impaired bind-
ing, indicating that ZF5 is necessary for Fip1 interaction. In the absence of CPSF160 and WDR33, a
His6-(StrepII)2–tagged fragment of CPSF30 comprising the ZF4 and ZF5 domains (CPSF30
ZF4-5) was
able to interact with Fip1CD (Figure 3C, lane 6). To corroborate this finding, we performed co-pre-
cipitation assays using bacterially expressed recombinant proteins. A maltose-binding protein
(MBP)-tagged CPSF30 construct containing zinc finger domains ZF1-5 (CPSF30ZF1-5) was efficiently
co-precipitated by glutathione S-transferase (GST-) fused Fip1CD (Figure 3—figure supplement 1B).
Interestingly, MBP-tagged CPSF30 construct comprising domains ZF1-4 (CPSF30ZF1-4) retained some
residual binding to Fip1CD, whereas a construct comprising ZF1-3 (CPSF30ZF1-3) did not, suggesting
that ZF4 also contributes to the CPSF30-Fip1 interaction in addition to ZF5.
Taken together, these results indicate that: (i) CPSF30 binds to CPSF160-WDR33 independently
of Fip1 and that its N-terminal ~60 residues (including ZF1) are necessary and sufficient for this inter-
action; (ii) Fip1 is tethered to the CPSF complex by its short ~7 kDa conserved domain (Fip1CD); and
(iii) the zinc finger domains ZF4 and ZF5 of CPSF30 are necessary and sufficient to mediate the inter-
action with Fip1. Furthermore, these conclusions are consistent with the cross-linking data between
each subunit (Figure 1B), as mapping the molecular cross-links of CPSF30 and Fip1 onto the molecu-
lar surface of the CPSF160-WDR33 heterodimer suggests that CPSF30 binds at, or close to, the
CPSF160-WDR33 molecular interface in proximity to the N-terminus of WDR33 (Figure 3—figure
supplement 2).
AAUAAA motif recognition is mediated by CPSF30 ZF2-3 domains and
an N-terminal motif in WDR33
As cross-linking and immunoprecipitation studies previously implicated human CPSF30 and WDR33
in direct interactions with the AAUAAA signal (Chan et al., 2014; Scho¨nemann et al., 2014), we
sought to investigate the structural requirements for PAS hexamer motif binding by the CPSF com-
plex and dissect the contributions of its individual subunits to AAUAAA motif recognition. To this
end, we quantified the binding of an AAUAAA-containing RNA by the CPSF core module and var-
iants thereof in a fluorescence polarization assay. The core module containing CPSF30FL and Fip1FL
bound the AAUAAA RNA with subnanomolar affinity (Figure 1A, Figure 4A). The affinity was sus-
tained and even increased with a complex containing Fip1CD and CPSF30 that lacked the C-terminal
ZK domain (CPSF30ZF1-5, Figure 4 and Table 2). A complex lacking Fip1 and containing only
CPSF30 domains ZF1-3 (CPSF30ZF1-3) also bound the AAUAAA RNA with extremely high affinity,
with our assay setting an upper boundary of ~100 pM for the equilibrium dissociation constant.
Although the observed increase in affinity upon removal of CPSF30 domains ZF4-5 and Fip1 is pres-
ently unclear, it is conceivable that CPSF30 ZF4-5 and/or Fip1 play an autoinhibitory role within
CPSF by sterically hindering the accessibility of CPSF30 ZF2-3 domains to the AAUAAA motif.
In contrast, deletion of the CPSF30 ZF3 domain (CPSF30ZF1-2) resulted in a dramatic (>2000 fold)
reduction in AAUAAA RNA binding, indicating that the ZF3 domain is essential for the recognition
of the PAS hexamer motif and that the presence of the ZF2 domain alone is not sufficient (Figure 4
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and Table 2). This is in good agreement with previous experiments demonstrating that both the ZF2
and ZF3 domains are required for interactions with the AAUAAA motif (Chan et al., 2014). Surpris-
ingly, however, no further reduction in AAUAAA RNA binding was observed when CPSF30 was fur-
ther truncated to remove the ZF2 domain (CPSF30ZF1), or omitted from the core module altogether,
indicating that in the absence of the ZF3 domain, the ZF2 domain of CPSF30 does not contribute to
AAUAAA binding. Binding was significantly decreased for all CPSF complex variants when a mutant
RNA containing a single-base substitution in the PAS hexamer motif (AAGAAA) was used (Figure 4—
figure supplement 1A), indicating that some specificity for the AAUAAA RNA is retained also in the
absence of CPSF30. Given that WDR33, as opposed to CPSF160, has been implicated in AAUAAA
recognition (Chan et al., 2014; Scho¨nemann et al., 2014), this suggests that WDR33 indeed con-
tributes to specific recognition of the PAS hexanucleotide.
We next sought to identify specific features in WDR33 involved directly in AAUAAA motif recog-
nition. Our cross-linking and mass spectrometry analysis indicated that an N-terminal motif located
immediately upstream of the NTD in WDR33 is a cross-linking hotspot. This region, which is not
resolved in the structure of the CPSF160-WDR33 subcomplex, is the only part of WDR33 that cross-
links to CPSF30 ZF2 and ZF3 domains, pointing to the spatial proximity of the two regions in the
CPSF subunits (Figure 1B). Furthermore, the sequence of the N-terminal motif is characterized by a
highly conserved pattern of positively charged residues (K46-K55) that might be involved in RNA
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Figure 4. CPSF30 ZF3 domain and WDR33 N-terminal motif are principal determinants of AAUAAA motif. Equilibrium binding measured by
fluorescence polarization of CPSF complex variants containing different CPSF30 constructs (A) and WDR33M1-K410 mutants (B) to an Atto532-labelled 16-
nucleotide RNA containing the PAS hexamer (AAUAAA). The polarization amplitude is normalized to 1. Error bars indicate standard error of means
(SEM) for five consecutive measurements of the same sample. Error bars indicate standard error of means (SEM) for five consecutive measurements of a
single representative sample. Each binding experiment was performed in triplicate and the mean KDvalues ± SEM are reported in Table 2.
DOI: https://doi.org/10.7554/eLife.33111.012
The following figure supplement is available for figure 4:
Figure supplement 1. Quantification of AAUAAA motif binding by CPSF complexes.
DOI: https://doi.org/10.7554/eLife.33111.013
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binding by ionic or cation-p interactions (Figure 4—figure supplement 1B). Based on these observa-
tions, we designed two WDR33M1-K410 constructs in which specific lysine and arginine residues in the
N-terminal motif were substituted with alanine (WDR33M1-K410 K46A/R47A and R49A/K50A). These
mutant proteins were still able to support the assembly of the CPSF160FL-WDR33M1-K410-CPSF30ZF1-
3 complex (Figure 4—figure supplement 1C), indicating that the N-terminal motif is not required
for the assembly of the core CPSF module. Next, we tested binding of the resulting complexes to
AAUAAA RNA in a fluorescence polarization assay. Both sets of mutations in WDR33 resulted in sub-
stantial reduction in affinity, with K46A/R47A binding with an equilibrium dissociation constant of
7.78 ± 0.78 nM (a ~70 fold reduction compared to wild-type WDR33M1-K410) and R49A/K50A with a
KD of 2.42 ± 0.66 nM (~25 fold reduction) (Figure 4B and Table 2). Notably, binding assays with the
mutant RNA containing a single-base substitution in the PAS hexamer motif (AAGAAA) revealed
that the K46A/R47A substitution in WDR33 results in a ~5 fold reduction in affinity compared to
wild-type WDR33M1-K410 (200 nM versus 43 nM, Table 2), whereas the R49A/K50A substitution leads
to ~12 fold reduction in affinity (500 nM versus 43 nM, Table 2). These results indicate that the posi-
tively charged lysine and arginine residues in the N-terminal region of WDR33 are involved in
AAUAAA motif recognition and contribute both to the affinity and specificity of AAUAAA binding.
Taken together, these experiments identify the ZF2 and ZF3 domains of CPSF30 and the N-terminal
motif of WDR33 as the critical determinants of AAUAAA recognition within the CPSF complex.
Discussion
A four-subunit core module of the mammalian CPSF complex has previously been shown to be suffi-
cient for the recognition of the AAUAAA hexamer motif of the polyadenylation signal via its CPSF30
and WDR33 subunits (Scho¨nemann et al., 2014). In this work, we sought to shed light on the struc-
tural architecture of the core module of human CPSF and its molecular mechanism of AAUAAA motif
recognition. Using cross-linking and mass spectrometry analysis, we define interactions within the
core module, revealing that WDR33 is a key component of the complex and identifying its N-termi-
nal region as an interaction hotspot in the absence of bound RNA, positioned in close proximity to
the remaining three subunits. The crystal structure of the CPSF160FL-WDR33Q35-K410 subcomplex
reveals extensive interaction between the two proteins resulting from shape complementarity of the
N-terminal domain of WDR33 and a deep cavity organized by the beta-propeller domains and
extended loops in CPSF160. The CPSF160-WDR33 subcomplex thus constitutes the structural scaf-
fold of the core polyadenylation module of the CPSF complex and provides an interaction platform
for the other CPSF subunits, including CPSF100 and CPSF73. Surprisingly, the architecture of the
CPSF160-WDR33Q35-K410 heterodimer, consisting of four WD40 beta-propeller domains, is highly
reminiscent of the DDB1-DDB2 complex involved in the detection and repair of UV-induced DNA
Table 2. Equilibrium dissociation constants of CPSF variants binding to wild-type or mutated PAS
hexamer RNA.
The equilibrium dissociation constants were determined using a fluorescence polarization binding
assay, as shown in Figures 1A and 4A,B and Figure 4—figure supplement 1A. The values reported
represent mean ±SEM of three independent measurements. For measurements denoted n.m. (not
measurable), the KD was above the range measurable by the assay (>>1 mM).
CPSF variant KD AAUAAA RNA KD AAGAAA RNA
CPSF160FL-WDR33M1-K410-CPSF30FL/Fip1FL 0.65 ± 0.90 nM 120 ± 23 nM
CPSF160FL-WDR33M1-K410-CPSF30ZF1-5/Fip1CD 0.11 ± 0.03 nM 70 ± 6 nM
CPSF160FL-WDR33M1-K410-CPSF30ZF1-3 <0.1 nM 43 ± 2 nM
CPSF160FL-WDR33M1-K410-CPSF30ZF1-2 >200 nM n.m.
CPSF160FL-WDR33M1-K410-CPSF30ZF1 >200 nM n.m.
CPSF160FL-WDR33M1-K410 >200 nM n.m.
CPSF160 FL-WDR33M1-K410(K46A-R47A)-CPSF30ZF1-3 7.78 ± 0.78 nM >200 nM
CPSF160 FL-WDR33M1-K410(R49A-K50A)-CPSF30ZF1-3 2.42 ± 0.66 nM >500 nM
DOI: https://doi.org/10.7554/eLife.33111.014
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damage, suggesting distant evolutionary relationships between the two molecular machineries. A
recent cryo-EM structure of the yeast Cft1-Pfs2-Yth1-Fip1 complex, which is orthologous and func-
tionally equivalent to the human CPSF160-WDR33-CPSF30-Fip1 complex and constitutes the polya-
denylation module of the yeast CPF complex, revealed striking similarities to the crystal structure of
the CPSF160-WDR33 heterodimer (Casan˜al et al., 2017). The yeast Cft1-Pfs2 subcomplex superim-
poses with the human CPSF160-WDR33 heterodimer with RMSDs of 2.56 A˚ for CPSF160 and Cft1
and 1.55 A˚ for WDR33 and Pfs2, indicating that the core CPSF scaffold is highly evolutionarily con-
served. Together, these structures reveal a high degree of structural homology between the yeast
CPF and mammalian CPSF complexes. Overall, the structure of the yeast complex is supportive of
the data presented in our study, as further discussed below.
Using co-expression and co-precipitation experiments, we dissect the individual inter-subunit
interactions underpinning the assembly of the core CPSF polyadenylation module. In addition to its
critical role in AAUAAA binding, CPSF30 functions in linking the CPSF160-WDR33 heterodimer and
Fip1. While the N-terminal ZF1 domain of CPSF30 is required for the interaction with CPSF160-
WDR33, the zinc finger domains ZF4 and ZF5 are involved in the recruitment of Fip1. This is good
agreement with previous studies of the yeast CPSF30 ortholog Yth1 showing that deletion of the
fifth zinc finger domain impairs interactions with Fip1p and Pap1p (the yeast orthologs of Fip1 and
PAP) and causes a polyadenylation defect in vitro (Barabino et al., 2000). Our interaction data are
consistent with the yeast Cft1-Pfs2-Yth1-Fip1 complex structure, in which the N-terminal region of
Yth1 up to and including ZF1 mediates the interaction with Cft1-Pfs2 (CPSF160-WDR33) while the
C-terminal ZF4 and ZF5 domains, together with Fip1, are structurally disordered (Casan˜al et al.,
2017). Notably, Yth1 ZF1 and ZF2 domains are located in the cleft formed by Cft1 and Pfs2, in good
agreement with our cross-linking data.
Using RNA-binding assays with complexes containing truncated CPSF30 proteins, we show that
the CPSF30 ZF2 and ZF3 domains play key roles in the specific recognition of the AAUAAA motif.
ZF3 additionally appears to play a structural role in the positioning of ZF2, since ZF2 does not
appear to be able to support RNA binding in the absence of ZF3. These results are in agreement
with experimental results showing that deletion of the ZF2 domain in the context of full-length
human CPSF30 abrogates AAUAAA RNA interactions in vitro, while point mutations in yeast Yth1p
that likely result in the unfolding of the second zinc finger domain abrogate mRNA polyadenylation
in vivo and in cell extracts (Barabino et al., 2000; Chan et al., 2014). The CPSF30 zinc knuckle
domain is not essential for the assembly of the core CPSF polyadenylation module, which is consis-
tent with the absence of this domain in yeast Yth1. However, deletion of the ZK domain in human
CPSF30 reduces the efficiency of its cross-linking to AAUAAA-containing RNA in vitro (Chan et al.,
2014), suggesting that the ZK domain also contributes to RNA binding. However, the precise role of
the ZK domain remains to be investigated.
Our co-precipitation and RNA binding assays reveal that Fip1 is a peripheral subunit that is dis-
pensable for specific recognition of the AAUAAA motif. The central conserved domain of Fip1
(Fip1CD) interacts with the ZF4 and ZF5 domains of CPSF30, as observed for the yeast orthologs
(Barabino et al., 2000). Given the conservation of the Fip1CD in yeast and protozoa, this interaction
mode is conserved across all eukaryotes, which enables the cleavage and polyadenylation complexes
to recruit, via Fip1, other polyadenylation factors including polyA polymerase and CStF (or the
related factor CFI in yeast). Given that Fip1 has intrinsic RNA-binding activity (Kaufmann et al.,
2004), the interaction also likely enables mammalian Fip1 to modulate polyA site definition, which
might be critical for the recently uncovered role of Fip1 in embryonic stem cell renewal and somatic
cell reprogramming (Lackford et al., 2014).
Although CPSF160 was originally assumed to be the CPSF subunit involved in AAUAAA RNA
binding, recent biochemical studies have provided compelling evidence that AAUAAA recognition is
mediated by WDR33 instead (Chan et al., 2014; Scho¨nemann et al., 2014). WDR33 can be cross-
linked to AAUAAA-containing RNA in vitro and transcriptome-wide photoactivatable ribonucleo-
side-enhanced cross-linking and immunoprecipitation (PAR-CLIP) analysis reveals that WDR33 binds
near the AAUAAA motif in vivo with high specificity (Chan et al., 2014; Scho¨nemann et al., 2014).
Using in vitro RNA-binding assays, we show that the CPSF160-WDR33 subcomplex retains substan-
tial affinity and specificity for the AAUAAA motif in the absence of CPSF30, indicating that WDR33
indeed contributes to specific recognition of the AAUAAA hexanucleotide. Upstream of the NTD,
human WDR33 contains a lysine/arginine-rich motif that is highly conserved in higher eukaryotes but
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not in the yeast orthologue Pfs2p (Figure 4—figure supplement 1B). In the absence of bound
AAUAAA RNA, the N-terminal motif is a cross-linking hotspot located in physical proximity to the
CPSF30 ZF3 domain, suggesting that the motif is involved in AAUAAA recognition. Consistent with
these observations, mutations of specific lysine or arginine residues in the motif impair AAUAAA
motif binding by the core CPSF module in vitro. Crucially, these mutations do not perturb module
assembly, suggesting that the WDR33 N-terminal motif is not involved in CPSF30 recruitment and
instead mediates direct interactions with the AAUAAA motif. Unlike in mammals, where polyA site
definition is strictly dependent on the A(A/U)UAAA hexanucleotide, the yeast cleavage and polyade-
nylation machinery recognizes a degenerate, A-rich sequences known as the positioning element
(Guo and Sherman, 1995; Chan et al., 2011). It is tempting to speculate that the difference in the
N-termini of human WDR33 and yeast Pfs2p might account for the differences in polyA site defini-
tion by the yeast and mammalian polyadenylation machineries.
Based on our structural observations and interaction analysis, we conclude that the CPSF160-
WDR33 heterodimer functions as an interaction platform, recruiting CPSF30 and indirectly Fip1, via
the ZF1 domain in CPSF30, and interacting with additional subunits of the CPSF complex including
CPSF100 and CPSF73 (Figure 5). AAUAAA motif binding occurs at the subunit interface of CPSF160
and WDR33 in close proximity to the WDR33 N-terminus, where the N-terminal lysine/arginine-rich
motif of WDR33 and the ZF2 and ZF3 domains of CPSF30 act synergistically to recognize the
AAUAAA motif in a sequence-specific manner. This enables the CPSF complex to bind the AAUAAA
motif with subnanomolar affinity and remarkable specificity. While this manuscript was in
Figure 5. Schematic model of the mammalian core CPSF complex bound to the PAS hexamer motif. CPSF160 and
WDR33 form heterodimer acting as a structural scaffold of the core CPSF complex. WDR33 interacts with CPSF160
through its NTD domain which is inserted in deep cavity formed by CPSF160 N- and C-terminal beta-propeller
domains (bP1 and bP3). CPSF30 connects CPSF160-WDR33 to Fip1, interacting with the former via its N-terminus
(including the zinc finger domain ZF1) and with the latter via its C-terminal zinc finger domains ZF4-5. The
hexanucleotide AAUAAA sequence is bound by CPSF30 ZF2-3 and a positively charged lysine/arginine-rich motif
located N-terminally of the NTD domain in WDR33. The latter is also a lysine cross-linking hot spot (indicated by a
yellow star) with CPSF30 and CPSF160. The dark dashed lines indicate the CPSF30 and CPSF160 domains
contacted by the cross-linking hotspot.
DOI: https://doi.org/10.7554/eLife.33111.015
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preparation, a cryoEM structure of the human CPFS160-WDR33-CPSF30-Fip1 complex bound to the
AAUAAA motif RNA was published, revealing that both the ZF2 and ZF3 domains of CPSF30 and
the N-terminal region are responsible for sequence-specific recognition of the AAUAAA motif
(Sun et al., 2017), in agreement with our structural and biochemical insights. Together, these studies
establish the structural framework for polyadenylation signal recognition by the core CPSF complex
and set the stage for further structural and mechanistic studies of the mammalian polyadenylation
machinery.
Materials and methods
Protein expression and purification
All constructs of human CPSF160 (Uniprot Q10570), WDR33 (Uniprot Q9C0J8-1), CPSF30 (Uniprot
O95639-3) and Fip1 (Uniprot Q6UN15-4) were cloned into ligation-independent MacroLab vectors
developed by Scott Gradia, University of California, Berkeley (Gradia et al., 2017). The constructs
were cloned in single-cassette, double-cassette or 438 MacroBac cloning system vectors as specified
in Supplementary file 1. For 438 MacroBac cloning system vectors, two, three or four subunits, as
appropriate, were combined in a single plasmid according to the MacroBac protocol (Gradia et al.,
2017) as specified in Supplementary file 1. Recombinant baculoviruses were generated using the
Bac-to-Bac system (Invitrogen) according to standard protocols. Sf9 insect cells were either infected
with one virus or co-infected with two viruses as specified in Supplementary file 1. GST-Fip1CD and
MBP-CPSF30 constructs used in pull-down experiments were cloned in the 2GT (Addgene #29707)
and 1M (Addgene #29656) vectors, respectively.
Recombinant CPSF complexes were expressed in Sf9 cells infected at a density of 1.0  106 ml 1.
For purifications of the CPSF160FL-WDR33Q35-K410 complex used for crystallization, cells were har-
vested 72 hr post infection, resuspended in 20 mM Tris-Cl pH 7.5, 150 mM NaCl, and 0.05%
Tween20, supplemented with Protease Inhibitor Cocktail (GE Healthcare), and lysed by sonication.
The complex was purified on Ni-NTA resin (Qiagen GmbH, Hilden, Germany) followed by purifica-
tion on glutathione sepharose 4 fast flow resin (GE Healthcare BioSciences AB, Uppsala, Sweden).
After removal of the tags by digestion with TEV protease, the complex was further purified by size
exclusion chromatography on a Superdex-200 column (GE Healthcare) in 20 mM HEPES pH 7.5, 150
mM KCl and 1 mM DTT.
For the purification of CPSF complexes used in fluorescence polarization RNA-binding measure-
ments, cells were harvested 72 hr post infection, resuspended in 20 mM Tris-HCl pH 7.5, 300 mM
NaCl, 10% glycerol, 0.05% Tween20, supplemented with Protease Inhibitor Cocktail (GE Healthcare),
and lysed by sonication. For complexes containing Fip1, 200 mM NaCl was used. The complexes
were purified on Ni-NTA resin (Qiagen) followed by purification on Streptactin superflow resin (IBA
GmbH, Goettingen, Germany) and size exclusion chromatography on a Superdex-200 column (GE
Healthcare) in 20 mM Tris-HCl pH 7.5, 150 mM NaCl and 1 mM DTT.
GST-Fip1CD and MBP-CPSF30 were expressed in E. coli BL21 Star (DE3) cells grown until an
OD600 of 0.6 and the expression was induced by addition of isopropyl-1-thio-b-D-galactopyranoside
(IPTG) to a final concentration of 0.1 mM. GST-Fip1CD was expressed at 20˚C overnight and MBP-
CPSF30 at 37˚C for 3 hr. Cells were harvested, resuspended in 20 mM Tris-HCl pH 7.5 and 500 mM
NaCl supplemented with 1 mM PMSF/AEBSF protease inhibitor, and lysed by sonication. GST-
Fip1CD was purified on glutathione sepharose 4 fast flow resin (GE Healthcare) and MBP-CPSF30 on
amylose resin (NEB Inc., Ipswich, MA, USA). Both proteins were further purified by size exclusion
chromatography on a Superdex-200 column (GE Healthcare) in 20 mM Tris-HCl pH 7.5, 150 mM
NaCl and 1 mM DTT.
Cross-linking and mass spectrometry analysis
80 mg of purified CPSF160FL-WDR33M1-G474-CPSF30FL-Fip1FL complex was cross-linked at a concen-
tration of 2 mg ml 1 with a final concentration of 1 mM equimolar mixture of isotopically labeled di-
succinimidyl suberate (DSS-d0, DSS-d12; CreativeMolecules Inc.) in a final volume of 40 ml of 20 mM
HEPES pH 7.5, 150 mM NaCl, 0.25 mM TCEP, incubated at 37˚C for 30 min at 500 rpm on a Ther-
momixer (Eppendorf AG, Hamburg, Germany), as previously described (Leitner et al., 2014). The
reactions were quenched with 50 mM (final concentration) of ammonium bicarbonate (NH4HCO3) for
Clerici et al. eLife 2017;6:e33111. DOI: https://doi.org/10.7554/eLife.33111 14 of 20
Research article Biochemistry Biophysics and Structural Biology
20 min at 37˚C and evaporated to dryness in a vacuum centrifuge. The dried pellets were dissolved
in 50 ml of 8 M urea, reduced with 2.5 mM TCEP for 30 min at 37˚C and alkylated with 5 mM iodoa-
cetamide (Sigma-Aldrich) for 30 min at room temperature, in the dark. Digestion was carried out
after diluting urea to 5 M with 50 mM NH4HCO3 and adding 1% (w/w) LysC protease (Wako Chemi-
cals GmbH, Neuss, Germany) for 3 hr at 37˚C and subsequently diluting to 1 M urea with 50 mM
NH4HCO3 and finally adding 2% (w/w) trypsin (Promega, Fitchburg, WI, USA) for 14 hr at 37˚C. Pro-
tein digestion was stopped by acidification with 1% (v/v) formic acid. Digested peptides were puri-
fied using Sep-Pak C18 cartridges (Waters, Milford, MA, USA) according to the manufacturer’s
protocol. Cross-linked peptides were enriched by peptide size exclusion chromatography (SEC) as
previously described (Leitner et al., 2014). SEC fractions were then reconstituted in 5% acetonitrile
and 0.1% formic acid and analyzed in duplicates on an HPLC (Thermo Easy-nLC 1000) coupled to a
mass spectrometer (Thermo Orbitrap Elite). Analytes were separated on an Acclaim PepMap RSLC
column (25 cm x 75 mm, 2 mm particle size, Thermo Scientific, Waltham, MA, USA) over a 60 min gra-
dient from 7% to 35% acetonitrile at a flow rate of 300 nl min 1. The mass spectrometer was oper-
ated in data-dependent acquisition (DDA) mode with MS acquisition in the Orbitrap analyzer at
120,000 resolution and MS/MS acquisition in the linear ion trap at normal resolution after collision-
induced dissociation. DDA was set up to isolate the top 10 precursors from an MS1 full scan with a
charge state of +3 or higher and a dynamic exclusion of 30 s (Leitner et al., 2014). MS data were
converted to mzXML format with msConvert (Chambers et al., 2012) and searched with xQuest/
xProphet (Walzthoeni et al., 2012) with an MS1 tolerance of 10 ppm and an MS2 tolerance of 0.2
and 0.3 Da for common ions and cross-link ions, respectively. Default settings for xQuest and xPro-
phet settings were selected (Leitner et al., 2014). The search database contained the peptide
sequences of the analyzed proteins and the corresponding decoy sequences. Cross-linked peptides
were identified with a minimal length of 5 amino acids and at least four bond cleavages or three
adjacent ones per peptide. Cross-linked peptides were defined as validated if they had a total ion
current explained higher than 0.1 and an xQuest score higher than 30, corresponding to an approxi-
mate false discovery rate of 10%. 18 (12%) of the 153 validated cross-linked sites could be mapped
to residues present in the atomic model of CPSF160-WDR33. From the subset of mapped cross-
linked residues, 12 had an Euclidean distance lower that 35 A˚, whereas six showed a distance
between 42 and 100 A˚. Notably, 5 of the six cross-linked sites originated from a common peptide
on CPSF160 (682-LALHKPPLHHQSK-694). Figures were prepared with xiNET (Combe et al., 2015),
UCSF Chimera (Pettersen et al., 2004) and UCSF Chimera X (Goddard et al., 2018).
CPSF160-WDR33 complex crystallization and structure determination
Crystals of CPSF160FL-WDR33Q35-K410 were obtained using the hanging drop vapor diffusion
method by mixing 0.5 ml of protein at 4.4 mg/ml and 0.5 ml of reservoir solution containing 11% (w/
v) PEG 3400, 37.5 mM ammonium formate and 112.5 mM magnesium formate (native data set) or
10% w/v PEG 3400 and 140 mM magnesium formate (Sulfur SAD data set). For derivatization with
tantalum bromide (Ta6Br12), crystals were grown in 8% w/v PEG3400 and 70 mM magnesium for-
mate and soaked in the reservoir solution containing 1 mM Ta6Br12 for one hour. For data collection,
crystals were cryoprotected by transfer to a solution containing 20% (v/v) glycerol and 80% (v/v) of
reservoir solution and flash cooled in liquid nitrogen. X-ray diffraction data were collected at beam
line X06DA (PXIII) of the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) and proc-
essed using XDS (Kabsch, 2010). Data collection statistics are shown in Table 1. Native and Ta6Br12-
SAD data comprised four data sets and native sulfur-SAD comprised 17 data sets collected on two
different crystals. All data sets were collected by exposing different parts of the same crystal, rotat-
ing the crystal through 360˚ in each data set and changing the kappa angle between datasets in 5˚
increments to ensure data completeness and redundancy. The structure was solved by a combina-
tion of molecular replacement (MR) and single-wavelength anomalous diffraction (SAD) using the
Phaser module in Phenix (Adams et al., 2010). A low-score MR solution (TFZ = 4) was obtained for
the native data set using a polyalanine model based on the DDB1 structure (PDB entry 3EI3) as
search model. The solution was subsequently used to perform MR-SAD on the sulfur- and Ta6Br12-
SAD datasets. A homology model of CPSF160 was fitted in the map obtained by Ta6Br12 MR-SAD,
manually rebuilt using Coot (Emsley and Cowtan, 2004) with the aid of the sulfur site positions
identified by sulfur-MR-SAD and refined using phenix.refine (Afonine et al., 2012). The resulting
atomic model was used to perform MR-SAD on the sulfur-SAD dataset, which yielded an improved
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map and additional sulfur sites. After several iterations of MR-SAD and manual building, whereby
the manually optimized model was used as input for sulfur MR-SAD yielding an optimized map that
allowed further building of the model, a homology model of WDR33 beta-propeller domain could
be fitted in the map and manually refined. Finally, the CPSF160-WDR33 model was used to perform
molecular replacement in the high resolution native data and manually built and improved using
Coot and refined using phenix.refine.
Pull-down assays
For pull-down assays from Sf9 cells expressing CPSF subunits, the cells were resuspended in 20 mM
Tris-Cl pH 7.5, 200 mM NaCl, 10% glycerol and 0.05% Tween20, and lysed by sonication. The clari-
fied lysate was incubated with 600 ml of NiNTA resin (Qiagen). After washing, the protein was eluted
and incubated directly with 30 ml Streptactin sepharose beads (GE Healthcare). The beads washed
three times with 1 ml of resuspension buffer and the protein eluted with SDS-PAGE loading buffer
at room temperature. The eluted samples and the input lysate were loaded on SDS-PAGE with no
prior boiling to avoid GFP denaturation, visualized on a Typhoon FLA9500 fluorescence scanner (GE
Healthcare) and subsequently stained with Coomassie brilliant blue R250.
For pull-down assays with purified proteins, 3 mg of GST-Fip1CD was immobilized on glutathione
sepharose four fast flow beads (GE Healthcare) and incubated with 40 mg of MBP-CPSF30. The
beads were washed three times with 500 ml of buffer containing 20 mM Tris-Cl pH 7.5, 150 mM
NaCl and 0.05% Tween20, the sample eluted with SDS-PAGE loading buffer and analyzed by SDS-
PAGE.
Fluorescence polarization RNA binding assays
Equilibrium binding experiments were carried out in a PheraStar FSX fluorescence plate reader
(BMG Labtech, Ortenberg, Germany) at 25˚C in 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT and
0.05% Tween 20 in 384-well non-binding surface, flat bottom black plates (Greiner) and 50 ml final
volume. The CPSF complex at different concentrations was incubated with 0.1 nM 5’-Atto532-
labelled L3 PAS RNA, either wild-type (CACACAAUAAAGGCAA) or mutant (CACACAAGAAAGG-
CAA). Fluorescence polarization was measured with an excitation filter with a central wavelength of
540 nm, and P and S emission filters with a central wavelength of 590 nm. The FP values were plot-
ted as a function of concentration and fitted to a one-site binding model accounting for ligand
depletion using Prism6 (GraphPad, Inc.). The polarization amplitude was normalized to 1. Error bars
indicate standard error of means (SEM) for five consecutive measurements of a single representative
sample. Each binding experiment was performed in triplicate and the mean KDvalues ± SEM are
reported in Table 2.
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